MedTrace Logo

Cannabis for Opioid Substitution Trial

NCT03859089 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1200

Last updated 2019-03-01

No results posted yet for this study

Summary

The purpose of this study is to define common strains of cannabis that adult chronic cancer and non-cancer pain syndrome patients are using as a replacement for opioids (narcotics). Identified strains, if any, will then be tested via randomized controlled trials to support an application for a Health Canada Drug Identification Number.

Conditions

  • Pain Syndrome
  • Opioid Use
  • Cannabis Use

Interventions

OTHER

Medical Cannabis

N/A - Observational Cohort Study

Sponsors & Collaborators

  • Cannabis Research Associates

    lead OTHER

Principal Investigators

  • Ira Price, MD · Cannabis Research Associates

Eligibility

Min Age
25 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-10-10
Primary Completion
2019-06-30
Completion
2019-10-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03859089 on ClinicalTrials.gov